| |
Algerian President Bouteflika has health crisis: TV Saturday, Apr 27, 2013 12:38 PM PDT | Top |
Drug maker Valeant in talks on $13 billion Actavis buy: source Saturday, Apr 27, 2013 06:13 AM PDT (Reuters) - Canada's largest listed drug maker, Valeant Pharmaceuticals International Inc, is in talks to buy generic drugmaker Actavis Inc for more than $13 billion, a person familiar with the situation told Reuters on Friday night. It is not clear how advanced the discussions are and a deal could still fall through, said the source, who declined to be identified because they are not allowed to speak to the media. A Valeant spokeswoman declined to comment and an Actavis spokesman could not be reached for comment outside of business hours. ... Full Story | Top |
China reports new bird flu case in Hunan province Saturday, Apr 27, 2013 04:56 AM PDT | Top |
Turkey's leader hits a nerve over country's "national drink" Saturday, Apr 27, 2013 04:50 AM PDT | Top |
U.S. agency moves against Nevada hospital cited for "patient dumping" Friday, Apr 26, 2013 09:19 PM PDT By Ronnie Cohen SAN FRANCISCO (Reuters) - Federal authorities have taken disciplinary action against a Las Vegas hospital cited for improperly sending newly released psychiatric patients by bus to neighboring California and other states in a practice called "patient dumping." The Rawson-Neal Psychiatric Hospital was warned it was in violation of Medicare rules governing the discharge of patients and could lose critical funding under the federal healthcare insurance program if it failed to correct the problem. ... Full Story | Top |
Rush to help airlines, travelers could crack open budget door Friday, Apr 26, 2013 08:16 PM PDT | Top |
U.S. sues Novartis over kickbacks Friday, Apr 26, 2013 08:06 PM PDT | Top |
Mothers group petitions Disney over sick pay laws Friday, Apr 26, 2013 05:10 PM PDT By Barbara Liston ORLANDO, Florida (Reuters) - Representatives of a national organization of mothers were prevented on Thursday from delivering a petition to Walt Disney World accusing it of trying to block laws that would require companies to provide paid sick leave for employees. "They were turned away and security was called," Kristin Rowe-Finkbeiner, executive director of MomsRising, told Reuters on Friday. ... Full Story | Top |
"Evidence" of Syria chemical weapons use not up to U.N. standard Friday, Apr 26, 2013 04:55 PM PDT By Anthony Deutsch AMSTERDAM (Reuters) - Assertions of chemical weapon use in Syria by Western and Israeli officials citing photos, sporadic shelling and traces of toxins do not meet the standard of proof needed for a U.N. team of experts waiting to gather their own field evidence. ... Full Story | Top |
Valeant in talks to buy Actavis for over $13 billion: WSJ Friday, Apr 26, 2013 04:47 PM PDT (Reuters) - Canada's biggest listed drug maker, Valeant Pharmaceuticals International Inc , is in talks to buy generic drugmaker Actavis Inc for more than $13 billion, Wall Street Journal reported, citing people familiar with the matter. The companies had been working towards an all-stock deal, when some of Actavis' directors came out against it around the middle of this week. But executives on the two sides are still working to resurrect the deal, the journal said. Valeant said in February it was in talks to make more acquisitions, and it remains open to discuss a potential "merger of equals. ... Full Story | Top |
UCLA professor to stand trial in fire that killed lab assistant Friday, Apr 26, 2013 04:38 PM PDT By Dan Whitcomb LOS ANGELES (Reuters) - A Los Angeles judge on Friday ordered a UCLA chemistry professor to stand trial on charges stemming from a 2008 fire in his university lab that fatally burned a 23-year-old research assistant, rejecting a defense request to dismiss the case. Patrick Harran faces up to 4 1/2 years in prison if he is convicted of all three counts of violating occupational health and safety standards in his organic chemistry laboratory at the University of California, Los Angeles. ... Full Story | Top |
Ambulatory Services taps Morgan Stanley to explore sale: sources Friday, Apr 26, 2013 02:44 PM PDT By Soyoung Kim and Greg Roumeliotis NEW YORK (Reuters) - Ambulatory Services of America Inc, a U.S. operator of healthcare facilities controlled by private equity firm Lindsay Goldberg LLC, has appointed Morgan Stanley to explore a sale, three people familiar with the matter said this week. The Nashville, Tennessee-based company may fetch between $700 million and $800 million based on earnings before interest, tax, depreciation and amortization of around $75 million, two of the people said on condition of anonymity because the sale process is confidential. ... Full Story | Top |
U.S. sues Novartis over kickbacks, second case this week Friday, Apr 26, 2013 01:46 PM PDT | Top |
Fraudulent versions of Allergan's Botox found in U.S. Friday, Apr 26, 2013 01:19 PM PDT By Toni Clarke (Reuters) - Fraudulent versions of the wrinkle treatment Botox, which is made by Allergan Inc and also used to treat headaches, underarm sweating and overactive bladder, are being sold in the United States, the Food and Drug Administration said on Friday. The FDA said in an alert posted on its website that the outer carton of the fraudulent Botox is counterfeit, and the vial inside is foreign and not approved for sale in the United States. "FDA cannot confirm that the manufacture, quality, storage, and handling of these products follow U.S. standards," the agency said. ... Full Story | Top |
Latin America threatened by mounting cancer epidemic: study Friday, Apr 26, 2013 01:10 PM PDT By Asher Levine SAO PAULO (Reuters) - Latin America's growing prosperity is fueling a cancer epidemic that threatens to overwhelm the region unless governments take urgent preventive action, a study published on Friday warned. A multinational team of researchers found the current state of cancer care and prevention in Latin America incompatible with the socioeconomic changes taking place in the region, where an increasingly urban populace faces mounting lifestyle-related cancer risks. ... Full Story | Top |
|
No comments:
Post a Comment